Navigation Links
Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs
Date:3/8/2011

that such defect has been waived by the Offeror), on the terms and subject to the conditions and restrictions of the Offer, during the Subsequent Offering Period have been accepted for payment.  As of the end of the Subsequent Offering Period 87,791,419 Shares are held by or tendered to the Offeror, representing 98.89% of the issued share capital of Crucell (which includes treasury shares held by Crucell).

Delisting, Deregistration and Termination of Reporting Obligations

Crucell intends to delist the Ordinary Shares on Euronext Amsterdam (Euronext) and the Swiss Exchange (SIX) and the ADSs on the NASDAQ Global Market Select (NASDAQ) as soon as reasonably practicable under applicable law and stock exchange rules and regulations.  Accordingly, Crucell intends to file a Form 25 with the U.S. Securities and Exchange Commission (SEC) to effect the delisting of the ADSs from NASDAQ.  Crucell intends to file a Form 15F with the SEC to deregister and terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended.  Crucell intends to delist the Ordinary Shares on Euronext and SIX after the Form 15F is filed.  Crucell reserves the right to delay or withdraw for any reason the filing of the Form 25 and Form 15F or the delisting on Euronext and/or SIX.

Statutory Buy-Out Proceedings

As the Offeror holds at least 95% of the Shares (excluding treasury shares held by Crucell), the Offeror intends to acquire the remaining Shares by means of buy-out proceedings (uitkoopprocedure) in accordance with article 2:92a and/or 359c of the Dutch Civil Code, to be initiated as soon as reasonably practicable. Further details will follow as circumstances require.

Additional InformationThis joint press release is issued pursuant to the provisions of Section 17 paragraph 4 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft).

On 8 December 2010
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
4. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
5. Johnson & Johnson Receives Approval from European Commission
6. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
7. Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
8. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
9. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
10. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
11. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... , Nov. 20, 2014  RedRick Technologies, a ... and reading room environment guidance, has helped the ... radiology reading room, which may also serve as ... Penn Medicine. "In line with ... College of Radiology,s Imaging 3.0 ™ initiative, ...
(Date:11/21/2014)... Michael DeMarco (42) erinnert sich ... Februar 2014 zugetragen hat. Seine Tochter Aly Demarco (13) ... Video - http://youtu.be/5cVoMCe0uiE „Man ... Training zu machen", erzählt Michael DeMarco . „Meine ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem Fahrrad, ...
Breaking Medicine Technology:Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
... /PRNewswire-FirstCall/ --,Wyeth Pharmaceuticals, a division of Wyeth ... clinical study,results on bifeprunox at an international ... an investigational,treatment for adult patients diagnosed with ... lipid profile, similar to,placebo. In addition, increases ...
... 30, 2007 /PRNewswire-FirstCall/ - Helix today,announced positive results ... Interferon Alpha-2b in women with human papilloma virus,(HPV) ... a clinically efficacious response to treatment,in nearly half ... an excellent safety profile, with no significant local,intolerance ...
Cached Medicine Technology:Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 2Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 3Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 4Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 5Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b 6
(Date:11/22/2014)... 2014 Discount-Dress.com is an important ... firm is to increase the company’s online market share by ... selection of bridesmaid dresses and announced a bridesmaid dress promotion ... until Dec. 30, 2014. All the dresses from this company ... , In fact, Discount-Dress.com is very good at manufacturing wedding ...
(Date:11/22/2014)... PA (PRWEB) November 22, 2014 "My ... the pain caused by the machine," said an inventor ... she had to go back a second time because ... invention idea." , She developed the patent-pending MAMO EASY ... breast cancer. The design saves the patient from the ...
(Date:11/22/2014)... 2014 (HealthDay News) -- The wide variety and complexity ... threat for people with food allergies, an expert warns. ... many types of food allergies that it can be ... Dr. Guha Krishnaswamy, director of allergy and clinical immunology ... hospital news release. "If you know you have ...
(Date:11/22/2014)... This month has been a historical time for Angeldress.co.uk, an ... reviews from some renowned review websites. Recently, the company has ... new selection of wonderful sexy wedding dresses to its website. ... and up to an 80% discount on any order over ... most suitable dress at Angeldress.co.uk, which has garnered a hard ...
(Date:11/22/2014)... Petersburg, FL (PRWEB) November 22, 2014 ... Kitchen Innovations are pleased to announce that Ashley ... the Thanksgiving #PayItForward contest. , Ms. Lombardo entered ... from Kitchen Innovations. She wrote of how her friend ... young daughters as a single mom. Despite medical bills ...
Breaking Medicine News(10 mins):Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2
... and support for those suffering from anorexia. ... Lothian//, said that all measures are being taken to ... Executive said that help would be provided for people ... in the Ombudsman's report. Mr Duncanson expressed his condolences ...
... the Indian Council of Medical Research (ICMR) today signed an ... medicinal plants or multi-herb formulations that have never been compiled. ... five years was signed by ICMR Director General N K ... ,As per the MoU, the ICMR will work towards validating ...
... With dengue, viral fever and malarial attacks reported in ... to appoint 30 doctors on contract and engage para-medical ... Mayor-in-Council (Health) Subodh De said that only dengue cases ... fanned out for surveillance in the affected areas., ...
... more than 2.85 lakh population in parts of Karnataka was coming ... ,As against 1.20 lakh cases reported till April this year, it ... so far, Minister for Health R Ashok said while making a ... government has failed to take urgent steps to contain the spread ...
... conducted on 28,000 postmenopausal women has shown that those who ... were benefited by a 3 percent reduction in risk of ... completely. ,Though the scientists were not able to place ... the diabetes risk, yet they strongly feel that the presence ...
... in the United States and the Far East who use ... blindness. ,Investigators have warned contact lens users about ... lead to the withdrawal of one type of a lens ... affected. ,Researchers have also explained that many people ...
Cached Medicine News:Health News:Investigations Reveal That Infections Due To Contact lens Could Cause Blindness 2
... offers a comprehensive array of features and ... and neonate patients, to magnetic resonance imaging ... the first MR monitor designed to meet ... patient monitoring. The new monitor is also ...
... InstaTest AFP is an immunochromatographic in vitro ... (AFP) in human serum. AFP is a ... to 74,000 D. Its normal concentration in ... are associated with hepatoma and ovarian, testicular ...
... simple and flexible solution. The Coag-A-Mate ... design, but offers full automation and ... high-volume systems. It is an easy ... also be used as a back-up ...
... is a fully automated open random ... and immunological, latex based coagulation tests. ... 5-position racks as sample carrier offers ... up to 70 reagents on-board with ...
Medicine Products: